isoxazoles has been researched along with Chagas Disease in 9 studies
*Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 5 (55.56) | 2.80 |
| Authors | Studies |
|---|---|
| Barbosa-Silva, AN; Brito, CRDN; da Câmara, ACJ; de Araújo-Neto, VT; de Medeiros, HR; de Sena, ER; Dos Santos, WV; Fagundes-Neto, JC; Ferreira, HRP; Galvão, LMDC; Gama, RA; Gomez, LCP; Guedes, PMM; Lima, RKDR; Nascimento, MSL; Queiroga, TBD | 1 |
| Acevedo-Arcique, CM; Baak-Baak, CM; Chan-Pérez, JI; Gutiérrez-Blanco, E; Jiménez-Coello, M; Ortega-Pacheco, A; Poot-Ramos, A | 1 |
| Alvedro, A; Cardinal, MV; Enriquez, GF; Gaspe, MS; Gürtler, RE; Laiño, MA; Macchiaverna, NP | 2 |
| Arruda, CCP; Baroni, ACM; Cardoso, IA; Carvalho, DB; Costa, PAN; das Neves, AR; de Albuquerque, S; Gaspari, PDM; Lopes, NP; Luccas, PH; Nonato, MC; Pelizaro, BI; Piranda, EM; Portapilla, GB; Shiguemoto, CYK; Silva, F | 1 |
| Alvedro, A; Cardinal, MV; Enriquez, GF; Gaspe, MS; Gürtler, RE; Laiño, MA | 1 |
| Aguiar, AP; Bozza, MT; Capasso, C; Feijó, DF; Pan, P; Parkkila, S; Rodrigues, GC; Supuran, CT; Vermelho, AB; Vullo, D | 1 |
| Ilies, MA | 1 |
| Arison, BH; Eskola, P; Kulsa, P; Miller, AK; Miller, BM; Miller, TW; Mrozik, H; Skeggs, H; Vandenheuvel, WJ; Zimmerman, SB | 1 |
2 trial(s) available for isoxazoles and Chagas Disease
| Article | Year |
|---|---|
Control of pyrethroid-resistant populations of Triatoma infestans, the main vector of Trypanosoma cruzi, by treating dogs with fluralaner in the Argentine Chaco.
Topics: Animals; Argentina; Chagas Disease; Dog Diseases; Dogs; Insect Vectors; Insecticides; Isoxazoles; Pyrethrins; Triatoma; Trypanosoma cruzi | 2022 |
An oral dose of Fluralaner administered to dogs kills pyrethroid-resistant and susceptible Chagas disease vectors for at least four months.
Topics: Administration, Oral; Animals; Chagas Disease; Dog Diseases; Dogs; Drug Resistance; Insect Vectors; Insecticides; Isoxazoles; Nymph; Pyrethrins; Random Allocation; Treatment Outcome; Triatoma | 2019 |
7 other study(ies) available for isoxazoles and Chagas Disease
| Article | Year |
|---|---|
Insecticidal efficacy of fluralaner (Bravecto
Topics: Animals; Brazil; Chagas Disease; Dog Diseases; Dogs; Female; Insect Vectors; Insecticides; Isoxazoles; Male; Nymph; Random Allocation; Triatoma | 2021 |
Evaluation of the effectiveness of fluralaner against adult stages of Rhodnius prolixus in dogs.
Topics: Animals; Chagas Disease; Dog Diseases; Dogs; Female; Insect Vectors; Isoxazoles; Male; Rhodnius; Trypanosoma cruzi | 2022 |
Treatment of dogs with fluralaner reduced pyrethroid-resistant Triatoma infestans abundance, Trypanosoma cruzi infection and human-triatomine contact in the Argentine Chaco.
Topics: Animals; Argentina; Chagas Disease; Dogs; Humans; Insect Vectors; Insecticides; Isoxazoles; Pyrethrins; Triatoma; Trypanosoma cruzi | 2022 |
Design, synthesis and antitrypanosomatid activity of 2-nitroimidazole-3,5-disubstituted isoxazole compounds based on benznidazole.
Topics: Antiprotozoal Agents; Chagas Disease; Cycloaddition Reaction; Humans; Isoxazoles; Nitroimidazoles; Structure-Activity Relationship; Trypanosoma cruzi | 2023 |
Design, synthesis, and evaluation of hydroxamic acid derivatives as promising agents for the management of Chagas disease.
Topics: Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cell Line, Tumor; Chagas Disease; Drug Design; Humans; Hydroxamic Acids; Isoenzymes; Isoxazoles; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Peptide Hydrolases; Protease Inhibitors; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi | 2014 |
New synthetic strategies for the management of Chagas disease (American trypanosomiasis).
Topics: Animals; Carbonic Anhydrase Inhibitors; Chagas Disease; Humans; Hydroxamic Acids; Isoxazoles; Protease Inhibitors; Trypanocidal Agents | 2014 |
Urinary metabolites of 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,2-benzisoxazole in the dog.
Topics: Animals; Antiprotozoal Agents; Biotransformation; Chagas Disease; Chromatography, Gas; Dogs; Female; Isoxazoles; Mass Spectrometry; Mice; Nitroimidazoles; Oxazoles; Salmonella | 1979 |